Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.380 | 0.390 | 0.010 |
Shares | 99.850 | 99.850 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.497 | 17.920 |
Price to Book | 3.836 | 3.008 |
Price to Sales | 2.450 | 2.197 |
Price to Cash Flow | 12.953 | 12.283 |
Dividend Yield | 2.380 | 2.054 |
5 Years Earnings Growth | 7.399 | 11.330 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 22.710 | 13.547 |
Technology | 12.160 | 23.503 |
Basic Materials | 11.450 | 4.138 |
Consumer Defensive | 10.770 | 7.797 |
Financial Services | 10.090 | 16.132 |
Industrials | 9.990 | 11.592 |
Consumer Cyclical | 8.870 | 10.463 |
Communication Services | 6.340 | 7.639 |
Energy | 4.940 | 3.648 |
Utilities | 2.430 | 2.726 |
Real Estate | 0.250 | 2.814 |
Number of long holdings: 50
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 4.27 | 254.49 | +1.88% | |
Alphabet A | US02079K3059 | 3.85 | 191.41 | +1.54% | |
Nestle | CH0038863350 | 3.53 | 73.98 | -0.30% | |
Roche Holding Participation | CH0012032048 | 3.48 | 247.40 | +0.28% | |
Holcim | CH0012214059 | 3.11 | 86.10 | -1.01% | |
Novartis | CH0012005267 | 3.07 | 86.72 | -0.37% | |
iShares SMIM CHF | CH0019852802 | 2.93 | 271.45 | +0.22% | |
Lindt & Spruengli N | CH0010570759 | 2.90 | 97,400.0 | -1.42% | |
Mastercard | US57636Q1040 | 2.83 | 528.03 | +0.91% | |
Hermes International | FR0000052292 | 2.81 | 2,304.00 | +0.39% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Stream Invest Acc | 28.81M | -6.77 | 2.22 | 4.91 | ||
AAE Global Strategy Fund | 3.98M | 17.46 | -1.48 | 4.81 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review